230 related articles for article (PubMed ID: 21852980)
41. Early alpha-lipoic acid therapy protects from degeneration of the inner retinal layers and vision loss in an experimental autoimmune encephalomyelitis-optic neuritis model.
Dietrich M; Helling N; Hilla A; Heskamp A; Issberner A; Hildebrandt T; Kohne Z; Küry P; Berndt C; Aktas O; Fischer D; Hartung HP; Albrecht P
J Neuroinflammation; 2018 Mar; 15(1):71. PubMed ID: 29514678
[TBL] [Abstract][Full Text] [Related]
42. Retinal pathology in experimental optic neuritis is characterized by retrograde degeneration and gliosis.
Manogaran P; Samardzija M; Schad AN; Wicki CA; Walker-Egger C; Rudin M; Grimm C; Schippling S
Acta Neuropathol Commun; 2019 Jul; 7(1):116. PubMed ID: 31315675
[TBL] [Abstract][Full Text] [Related]
43. Mitochondrial Uncoupler Prodrug of 2,4-Dinitrophenol, MP201, Prevents Neuronal Damage and Preserves Vision in Experimental Optic Neuritis.
Khan RS; Dine K; Geisler JG; Shindler KS
Oxid Med Cell Longev; 2017; 2017():7180632. PubMed ID: 28680531
[TBL] [Abstract][Full Text] [Related]
44. Spermidine alleviates severity of murine experimental autoimmune encephalomyelitis.
Guo X; Harada C; Namekata K; Kimura A; Mitamura Y; Yoshida H; Matsumoto Y; Harada T
Invest Ophthalmol Vis Sci; 2011 Apr; 52(5):2696-703. PubMed ID: 21228387
[TBL] [Abstract][Full Text] [Related]
45. Transgenic inhibition of astroglial NF-κB protects from optic nerve damage and retinal ganglion cell loss in experimental optic neuritis.
Brambilla R; Dvoriantchikova G; Barakat D; Ivanov D; Bethea JR; Shestopalov VI
J Neuroinflammation; 2012 Sep; 9():213. PubMed ID: 22963651
[TBL] [Abstract][Full Text] [Related]
46. Transcranial direct current stimulation as a preventive treatment in multiple sclerosis? Preclinical evidence.
Marenna S; Huang SC; Rossi E; Castoldi V; Comi G; Leocani L
Exp Neurol; 2022 Nov; 357():114201. PubMed ID: 35963325
[TBL] [Abstract][Full Text] [Related]
47. RGC Neuroprotection Following Optic Nerve Trauma Mediated By Intranasal Delivery of Amnion Cell Secretome.
Grinblat GA; Khan RS; Dine K; Wessel H; Brown L; Shindler KS
Invest Ophthalmol Vis Sci; 2018 May; 59(6):2470-2477. PubMed ID: 29847652
[TBL] [Abstract][Full Text] [Related]
48. Systemic Mesenchymal Stem Cell Treatment Mitigates Structural and Functional Retinal Ganglion Cell Degeneration in a Mouse Model of Multiple Sclerosis.
Gramlich OW; Brown AJ; Godwin CR; Chimenti MS; Boland LK; Ankrum JA; Kardon RH
Transl Vis Sci Technol; 2020 Jul; 9(8):16. PubMed ID: 32855863
[TBL] [Abstract][Full Text] [Related]
49. Simvastatin treatment does not protect retinal ganglion cells from degeneration in a rat model of autoimmune optic neuritis.
Sättler MB; Diem R; Merkler D; Demmer I; Boger I; Stadelmann C; Bähr M
Exp Neurol; 2005 May; 193(1):163-71. PubMed ID: 15817275
[TBL] [Abstract][Full Text] [Related]
50. Functional evolution of visual involvement in experimental autoimmune encephalomyelitis.
Marenna S; Huang SC; Castoldi V; d'Isa R; Costa GD; Comi G; Leocani L
Mult Scler J Exp Transl Clin; 2020; 6(4):2055217320963474. PubMed ID: 35145730
[TBL] [Abstract][Full Text] [Related]
51. Deletion of Arginase 2 Ameliorates Retinal Neurodegeneration in a Mouse Model of Multiple Sclerosis.
Palani CD; Fouda AY; Liu F; Xu Z; Mohamed E; Giri S; Smith SB; Caldwell RB; Narayanan SP
Mol Neurobiol; 2019 Dec; 56(12):8589-8602. PubMed ID: 31280447
[TBL] [Abstract][Full Text] [Related]
52. Further Evidence on Efficacy of Diet Supplementation with Fatty Acids in Ocular Pathologies: Insights from the EAE Model of Optic Neuritis.
Locri F; Cammalleri M; Pini A; Dal Monte M; Rusciano D; Bagnoli P
Nutrients; 2018 Oct; 10(10):. PubMed ID: 30301197
[TBL] [Abstract][Full Text] [Related]
53. Limiting Neuronal Nogo Receptor 1 Signaling during Experimental Autoimmune Encephalomyelitis Preserves Axonal Transport and Abrogates Inflammatory Demyelination.
Lee JY; Kim MJ; Thomas S; Oorschot V; Ramm G; Aui PM; Sekine Y; Deliyanti D; Wilkinson-Berka J; Niego B; Harvey AR; Theotokis P; McLean C; Strittmatter SM; Petratos S
J Neurosci; 2019 Jul; 39(28):5562-5580. PubMed ID: 31061088
[TBL] [Abstract][Full Text] [Related]
54. Calpain inhibitor attenuated optic nerve damage in acute optic neuritis in rats.
Das A; Guyton MK; Smith A; Wallace G; McDowell ML; Matzelle DD; Ray SK; Banik NL
J Neurochem; 2013 Jan; 124(1):133-46. PubMed ID: 23106593
[TBL] [Abstract][Full Text] [Related]
55. Alterations of peripheral nerve excitability in an experimental autoimmune encephalomyelitis mouse model for multiple sclerosis.
Teixeira NB; Picolo G; Giardini AC; Boumezbeur F; Pottier G; Kuhnast B; Servent D; Benoit E
J Neuroinflammation; 2020 Sep; 17(1):266. PubMed ID: 32894170
[TBL] [Abstract][Full Text] [Related]
56. Complex I subunit gene therapy with NDUFA6 ameliorates neurodegeneration in EAE.
Talla V; Koilkonda R; Porciatti V; Chiodo V; Boye SL; Hauswirth WW; Guy J
Invest Ophthalmol Vis Sci; 2015 Jan; 56(2):1129-40. PubMed ID: 25613946
[TBL] [Abstract][Full Text] [Related]
57. Treatment with MDL 72527 Ameliorated Clinical Symptoms, Retinal Ganglion Cell Loss, Optic Nerve Inflammation, and Improved Visual Acuity in an Experimental Model of Multiple Sclerosis.
Liu F; Alfarhan M; Baker L; Shenoy N; Liao Y; Henry-Ojo HO; Somanath PR; Narayanan SP
Cells; 2022 Dec; 11(24):. PubMed ID: 36552864
[TBL] [Abstract][Full Text] [Related]
58. 3-Dimensional Immunostaining and Automated Deep-Learning Based Analysis of Nerve Degeneration.
Drake SS; Charabati M; Simas T; Xu YKT; Maes EJP; Shi SS; Antel J; Prat A; Morquette B; Fournier AE
Int J Mol Sci; 2022 Nov; 23(23):. PubMed ID: 36499143
[TBL] [Abstract][Full Text] [Related]
59. Microglia response in retina and optic nerve in chronic experimental autoimmune encephalomyelitis.
Horstmann L; Kuehn S; Pedreiturria X; Haak K; Pfarrer C; Dick HB; Kleiter I; Joachim SC
J Neuroimmunol; 2016 Sep; 298():32-41. PubMed ID: 27609273
[TBL] [Abstract][Full Text] [Related]
60. Time-Dependent Progression of Demyelination and Axonal Pathology in MP4-Induced Experimental Autoimmune Encephalomyelitis.
Prinz J; Karacivi A; Stormanns ER; Recks MS; Kuerten S
PLoS One; 2015; 10(12):e0144847. PubMed ID: 26658811
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]